SailPoint and Okta Partner to Deliver End-to-End Identity for the Enterprise
SailPoint Technologies Holdings, Inc. (NYSE: SAIL) and Okta, Inc. (NASDAQ: OKTA) today announced a strategic partnership to provide end-to-end identity for the enterprise – helping organizations balance providing simple, secure user access with meeting complex compliance and security requirements.
To increase efficiency and productivity, enterprises are adopting more cloud applications, building and deploying their own cloud solutions – and all while maintaining significant on-premises infrastructure. The most effective way to maintain security and compliance in this increasingly complex and largely heterogeneous environment is to monitor and protect an individual’s identity.
By working together, SailPoint and Okta provide organizations with an even stronger identity solution that securely and effectively authenticates, provisions and governs access to all applications and data across the enterprise. Enterprises can manage a user’s access throughout the entire lifecycle, including initial onboarding, providing secure single sign-on and multi-factor authentication for application access, and automated off-boarding as users change roles or leave an organization. Key identity functions such as access certification and provisioning of any application, self-service support for password resets, and access requests are all automated. The SailPoint and Okta pairing ensures authorization policies are enforced, and that user access activity is documented, secure and compliant – providing enterprises with the full breadth of automated access and identity governance controls needed to securely optimize and govern work across today’s heterogeneous IT environment.
“Identity is only growing in importance. Today, organizations have to connect to and manage a variety of cloud and on-premises tools their workers need to be productive, and they have to balance ease of use with secure access from anywhere, and on any device,” said Todd McKinnon, CEO and Co-founder of Okta. “That’s why our customers look to us to solve their most complex identity challenges. Okta’s strength in securely connecting and managing people and technology, combined with SailPoint’s strength in identity governance, will provide a seamless experience for customers across industries. The success of our customers is our top priority, and we’re pleased to partner with SailPoint to make security and compliance easier.”
“It is an exciting time to be in identity. When two identity leaders, both known for disrupting and innovating in their markets, join forces to make security and compliance easier, it provides huge value to our joint customers,” said Mark McClain, CEO and Co-founder of SailPoint. “Together, we help companies balance simple, secure user access and management with the necessary governance and compliance controls required to not only ensure users have the right access, but also that their access adheres to corporate policy. This balancing act is difficult for enterprises to manage today, which is why our partnering with Okta is so important. We are thrilled to be teaming up together to deliver the best-in-class identity solution our customers need as they manage identity in today’s modern workforce.”
Organizations such as Sacramento Municipal Utility District are already using SailPoint and Okta today to address their unique access and identity governance requirements.
“At SMUD, our culture revolves around a commitment to innovation and efficiency, and that certainly extends to our investment in key technologies that enable us to innovate and to drive business efficiencies wherever possible,” said John Peters, Senior Enterprise Infrastructure Specialist, Sacramento Municipal Utility District. “We’re excited to see Okta and SailPoint team up, because the integrated identity solution will allow us to seamlessly provide our workforce with secure access to applications with the confidence that we're maintaining the necessary governance over that access.”
Because the realities of modern business require that enterprises do more with less, and do it faster, organizations like Accenture and Deloitte are looking for solutions that provide effective policies, automation and workflows critical to streamlining processes and increasing productivity to support their customers’ IT and business strategies.
“We believe this strategic relationship between SailPoint and Okta can add significant value for our clients and aligns with our vision for the evolution and natural progression of the Identity services market,” said Michael Wyatt, Deloitte Risk and Financial Advisory principal and Cyber Risk Services Identity Management practice leader, Deloitte & Touche LLP. “This strategic relationship brings to the industry an integrated identity solution that can provide visibility, control, and automation with user authentication, user access and the ability to govern those who have access.”
SailPoint and Okta will work with customers to determine the best way to manage and protect all identities – employees, customers, partners, contractors – within an enterprise. For more information about using SailPoint and Okta, visit https://www.sailpoint.com/partners/okta
SailPoint: The Power of Identity™
SailPoint, the leader in enterprise identity management, brings the Power of Identity to customers around the world. SailPoint’s open identity platform gives organizations the power to enter new markets, scale their workforces, embrace new technologies, innovate faster and compete on a global basis. As both an industry pioneer and market leader in identity governance, SailPoint delivers security, operational efficiency and compliance to enterprises with complex IT environments. SailPoint's customers are among the world’s largest companies in a wide range of industries, including: 6 of the top 15 banks, 4 of the top 6 healthcare insurance and managed care providers, 8 of the top 15 property and casualty insurance providers, 5 of the top 15 pharmaceutical companies, and 6 of the largest 15 federal agencies.
Okta: The Foundation for Secure Connections Between People and Technology
Okta is the leading independent provider of identity for the enterprise. The Okta Identity Cloud connects and protects employees of many of the world's largest enterprises. It also securely connects enterprises to their partners, suppliers and customers. With over 5,000 integrations, the Okta Identity Cloud enables simple and secure access from any device. Thousands of customers, including Experian, 20th Century Fox, LinkedIn, Flex, News Corp, Dish Networks, and Adobe trust Okta to work faster, boost revenue and stay secure. Okta helps customers fulfill their missions faster by making it safe and easy to use the technologies they need to do their most significant work.
SailPoint, the SailPoint logo, IdentityIQ, IdentityNow, IdentityAI, SecurityIQ and all techniques are trademarks or registered trademarks of SailPoint Technologies, Inc. in the U.S. and/or other countries. All other products or services are trademarks of their respective companies.
Please see www.deloitte.com/us/about for a detailed description of the Deloitte & Touche LLP legal structure.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 10:49 | Pressemelding
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha